At the Managing Director level, the deal work itself rarely takes the most time. The time goes to the production work that surrounds it: reconstructing the deal narrative from a fragmented analyst draft, recalibrating the IC memo's risk framing to match what the committee actually cares about, prepping for a deal meeting where every question can go sideways if the preparation is shallow.
The short version: Managing Directors can use Claude to compress the production work around IC memos and deal meetings into a structured, repeatable workflow—without outsourcing the judgment that defines the MD's role. The workflow is built on the assumption that the MD already has a clear analytical view of the deal. Claude's job is to help convert that view into well-framed documents and meeting preparation, faster, so the MD's time returns to where it belongs: on the transaction, the relationship, and the decision.
If you regularly spend two or three hours rewriting a junior memo before it is fit for the investment committee—or if deal meeting prep is a scramble because the supporting materials are never quite organized the way you need them—this workflow addresses both problems directly.
Who this is for
- Managing Directors, Senior MDs, and Partners at private equity, growth equity, credit, and infrastructure funds who own IC presentations
- Managing Directors in investment banking preparing deal committee or approval committee materials
- Senior deal professionals at family offices and sovereign wealth funds who present to senior investment committees
- VPs and Principals who are transitioning into MD-level communication responsibilities for the first time
- Any senior deal professional who owns the narrative translation between the analytical team and the investment decision-makers
This is not for you if: you are an analyst or associate building the initial deal model or conducting primary diligence. This workflow assumes analytical work is substantially complete and the MD's challenge is converting that analysis into IC-grade communication and decision-ready meeting preparation.
The IC Memo and Deal Meeting Workflow
Investment committee memos follow a recognized structure: deal overview, investment thesis, financial summary, key risks and mitigants, structure, and a recommendation. Deal meetings layer on top of that: the narrative coherence, the committee's anticipated questions, the supporting materials the room will actually use.
Both have the same underlying problem: they require a clear, defensible deal narrative that most analyst drafts get partially right and partially wrong. The MD's job—the actual value-add at that level—is to get the narrative precisely right. That judgment cannot be delegated. The production work around it can be significantly accelerated.
Step 1: Establish the IC memo standard before a specific deal
The most productive setup you can do is spend ninety minutes defining your firm's IC memo standard in a reusable Claude prompt—before you apply it to any specific deal. This is a one-time investment.
The standard should capture: your firm's typical memo sections in order, the level of analytical depth expected in each section, the risk framing your committee prefers (categorical vs. probability-weighted vs. narrative), the structure of the recommendation section, the tone (formal and precise, or analysis-forward and concise), and any recurring committee sensitivities that apply across deals (sponsor quality, leverage levels, market cyclicality, management team track record).
Once built, this standard becomes the architectural reference for every IC memo workflow. You do not recreate it per deal—you reference it and update it when your committee's expectations evolve.
A note on confidentiality: deal-specific details—company names, target financials, sponsor identities, deal terms, valuations—should not be pasted into Claude in raw form. The workflow below is designed around abstracted and directional inputs. Describe the deal's profile, not its specifics. Your firm's data handling policies govern this; the practice is to describe rather than transcribe.
Step 2: Diagnose the analyst draft, don't edit it
The most common MD time-sink is opening an analyst memo draft and editing it line by line. This is inefficient and demoralizing for the junior team. It is also the wrong intervention.
Before making a single edit to the draft, run a diagnostic pass with Claude. Describe the deal profile and the draft's structure (not its specific content), and ask Claude to generate the diagnostic questions an IC reviewer would ask about a memo of this type—by section.
This produces a structured list of what a well-formed IC memo for this deal category must contain and how each section should hold together. Then compare that diagnostic against the draft.
Now you know exactly what is missing and what is miscalibrated—before you spend any time in the document. You are not editing; you are directing. You tell the analyst what specific sections to rebuild, what analytical gaps to fill, and what framing to change. The MD's time in the draft drops from two hours to thirty minutes.
Step 3: Build the investment thesis section from your own analysis
The investment thesis is the section analysts consistently undershoot. They write what the company does. You need to communicate why this investment, at this price, in this structure, at this moment in the market cycle, is the right decision.
Do not ask Claude to write the thesis from the analyst's draft. Instead, give Claude your own articulation—rough notes, bullet points, a voice memo transcript if you prefer—of the three to five reasons the deal is worth doing and the two to three conditions under which it fails. Be specific about what the return driver is (multiple expansion, earnings growth, multiple paths to value, specific operational improvement), and what the IC is most likely to push back on.
Prompt Claude to structure that articulation into a tight investment thesis section that: opens with a one-sentence thesis statement, supports it with the ranked investment merits, and closes with the primary condition the committee should evaluate before approving.
Review this output carefully. The thesis section is the MD's clearest statement of professional judgment in the memo. It should read like you wrote it, because intellectually you did.
Step 4: Build the risk section with explicit committee calibration
Risk sections fail in two ways: they either list generic macro risks that apply to every deal (interest rates, competition, regulatory change) without deal-specific grounding, or they bury the real risks in language so hedged that the committee has to excavate them.
Before prompting Claude, prepare a frank list of: the three or four risks that, if they materialize, would cause the investment to underperform or fail; the mitigants in place (structural, contractual, operational, sponsor-specific); and the risk the committee is most likely to focus on, whether or not it is the one you consider most material.
Prompt Claude to draft the risk section with the following discipline: each risk stated plainly, its likelihood and magnitude described qualitatively (not quantitatively, unless your firm uses probability-weighted frameworks), the mitigant described concretely, and a sentence on the residual risk the firm is accepting.
Then run a second prompt: "What risk is a diligent committee member likely to raise that is not addressed in this risk section?" This surfaces what the section is missing before the committee meeting surfaces it in the room.
Step 5: Build the deal meeting preparation package
IC meeting preparation is a separate workflow from memo production. The memo is the record. The meeting is the performance—and for Managing Directors, a weak meeting performance on a good deal is a recoverable but avoidable problem.
Build the meeting preparation package with Claude in three parts:
The Q&A brief. Based on the deal profile and the risk section you have already built, prompt Claude to generate the twelve to fifteen questions the committee is most likely to ask—and for each, a one to three sentence direct answer. This is not a substitute for knowing the deal; it is a forcing function to confirm you can answer concisely and directly before you are in the room.
The supporting materials index. Tell Claude the sections of the memo and ask it to generate a checklist of the supporting exhibits a committee member would want to see if they pushed deeper on each section. This is the gap audit for your diligence package—what is in the appendix, what is missing, and what a skeptical committee member might ask to see that you don't currently have.
The one-sentence-per-section summary sheet. For a deal that has been through multiple diligence rounds, information accumulates and the committee may have lost the thread. Produce a one-page summary that reduces each major memo section to one sentence. This is the chair's pre-read, the answer to "remind me where we are on this," and your own orientation tool before you walk into the room.
Step 6: Run the narrative coherence pass
Before the memo goes to the committee, run a final Claude prompt that evaluates narrative coherence across the full document. Give Claude the key claims from each major section—the thesis, the financial summary, the risk section, the recommendation—as a structured list and ask: "Are there claims in any section that are inconsistent with or unsupported by the claims in another section?"
This surfaces the internal contradictions that undermine credibility in an IC meeting: a thesis that claims defensive characteristics in a business that the financial section shows is highly cyclical; a recommendation that says the risk-reward is compelling while the risk section lists three unmitigated concerns.
Fix the contradictions before the memo is submitted. Committees notice.
Example: The Risk-Thesis Coherence Check
Suppose you are working on a growth equity deal in a software business. The investment thesis states that the company's net revenue retention is a primary value driver. The risk section mentions customer concentration as a risk, but the mitigant is generic.
A narrative coherence check would surface this immediately: if net revenue retention is the thesis driver, then customer concentration is not just a risk—it is a direct threat to the primary investment thesis. The risk section needs to be rewritten to reflect that the committee is being asked to accept customer concentration risk as a deliberate bet on the NRR pattern holding. That is a different framing than a pro forma risk disclosure.
This kind of calibration—making the risk section actively serve the thesis, rather than listing adjacent concerns—is exactly where MD judgment matters. Claude does not have the analytical view to produce this framing without your direction. But once you identify the coherence gap, Claude helps you rewrite it precisely.
Checklist: IC Memo Quality Standards
Before submitting any IC memo produced with this workflow, verify:
- The investment thesis opens with a single, defensible sentence that states the specific reason this investment creates value
- Each investment merit in the thesis is deal-specific, not category-generic
- The return driver is explicitly stated and modeled in the financial section
- Each risk is stated plainly, not euphemistically—a committee should be able to see exactly what outcome the firm is accepting exposure to
- Every risk has a stated mitigant that is concrete (structural, contractual, operational, sponsor) not aspirational
- The recommendation section states the committee's decision in plain terms—what they are being asked to approve
- There are no claims in the executive summary that are not supported by the body of the memo
- The thesis and the risk section are coherent—the risk section addresses the risks that are most material to the thesis
- No deal-specific company names, financials, sponsor identities, or deal terms were pasted directly into Claude at any point
- The memo has been read aloud by the MD or a direct report—passive voice and overly hedged language fail this test
Where the workflow breaks: four points of failure
Failure 1: Using Claude to generate the investment thesis from analyst materials
The investment thesis is not something Claude can derive from a deal summary. It requires the MD's judgment about return drivers, committee dynamics, deal structure, and market context. If you prompt Claude with "here is the deal summary, write me an investment thesis," you will get a plausible-sounding synthesis of the materials. It will miss the specific analytical view that makes the thesis defensible in the room. Build the thesis from your own articulation first.
Failure 2: Treating the Q&A brief as a complete substitute for deal preparation
The Q&A brief is a forcing function, not a comprehensive preparation. It surfaces the questions you can answer quickly and directly. It also surfaces the questions you cannot answer well—and those are what you need to spend preparation time on. Use the brief to identify the gaps, then address the gaps through additional diligence or material preparation, not through better rehearsed non-answers.
Failure 3: Submitting the first coherence pass as the final memo
The coherence pass is a diagnostic, not an editing pass. It identifies contradictions and gaps. You still need to make the judgment calls about how to resolve them. A coherence pass that flags a risk-thesis misalignment does not tell you whether to fix the thesis, fix the risk section, or surface the tension explicitly to the committee as a deal-level consideration. That is an MD decision.
Failure 4: Building a new setup each deal because no standard exists
The most expensive version of this workflow is building the IC memo standard from scratch every time you apply it to a new deal. The setup investment pays back across dozens of transactions. If you are doing more than three or four IC memos per year, a well-built standard pays for itself in the first quarter.
Using this workflow at the team level
For Managing Directors managing a VP or Principal team that drafts IC materials: the same workflow scales with modification. The diagnostic prompt—what a well-formed IC memo for this deal type must contain—becomes a shared review standard that your VPs can run against their own drafts before bringing them to you.
This does not mean the VP is doing the MD's review work. It means the draft that arrives on your desk has already been checked against the structural standard, and you are reviewing for judgment, framing, and committee calibration—not for missing sections or generic risk language.
The result is that your time in the draft is compressed, the VP receives more directionally useful feedback, and the memo that goes to committee is tighter. Across a full deal year, this compresses in ways that matter for MD capacity.
The professional judgment question for deal professionals
Investment committee processes exist precisely because consequential capital allocation decisions require experienced judgment under conditions of uncertainty. The question senior deal professionals ask about this kind of workflow is reasonable: does using Claude to structure IC materials compromise the integrity of the judgment process?
No. The judgment—what this investment is, why it is worth doing, what risks the firm is accepting—is entirely the MD's. Claude handles the compositional work: building structure, identifying gaps, improving coherence, producing meeting preparation materials. None of that is judgment work. All of it is production work.
What you never delegate to this workflow: the investment thesis, the risk calibration, the recommendation, the committee framing, the decision about what the committee needs to hear and in what order. Those are MD-level judgments. Claude has no view on your deal, your committee's risk appetite, or the market conditions that make this the right or wrong moment. You do.
The integrity practice is the same as it is with any external advisor: describe rather than transcribe sensitive deal terms, review every output before it enters a formal document, and apply your firm's data governance standards throughout.
How this becomes a repeatable deal operating system
The first deal through this workflow will take more time than you expect, because you are building the architecture—the IC memo standard, the diagnostic prompts, the coherence check framework, the meeting preparation template—for the first time.
By the third or fourth deal, the architecture is stable. The standard exists. The prompts are saved. The diagnostic questions are calibrated to your committee's sensitivities. The meeting preparation package builds in two hours instead of a full day.
At that point, the workflow is not a productivity tool for a single deal. It is an operating system for your deal practice. It runs consistently across your team, your deal flow, and your calendar. Your time returns to the transactions themselves—the relationship management, the analytical judgment, the negotiation, the committee dynamics—rather than to the production work that surrounds them.
If you want to build this operating system fully—with a complete prompt vault, a review layer designed for the IC communication context, and a deal-cycle template that runs across diligence, committee, and post-close—The Leveraged Executive for Deal Professionals is built specifically for MD-level deal work.
Not sure which course fits your work? Take the 6-question course selector.
Browse the full courses library to see the complete range of available tracks.
Frequently asked questions
Can an MD use this workflow without exposing deal-specific confidential information to Claude?
Yes, with deliberate input framing. The workflow is built around abstracted, directional inputs—deal category, investment merits described generically, risk types and mitigants described without naming companies, counterparties, or specific financial terms. Claude does not need actual deal details to help structure crisp IC narrative. Apply your firm's data governance standards as you would with any outside resource: describe rather than transcribe.
How does this workflow handle the IC memo sections that are primarily quantitative?
The workflow is focused on narrative sections: investment thesis, risk section, recommendation, and executive summary. For quantitative sections—financial model outputs, sensitivity tables, returns analysis—Claude's role is limited to structural framing and consistency checking, not analytical generation. The numbers come from your model; the workflow helps you communicate what the numbers mean.
Is this workflow appropriate for MDs at smaller firms or family offices without a formal IC process?
Yes, often more so. MDs at smaller deal platforms frequently carry more of the memo production burden themselves without the same junior team support. The workflow's diagnostic pass—generating what a well-formed memo for this deal type must contain—is particularly useful when there is no institutional template to reference. The IC standard you build becomes the firm's standard.
How does this workflow change the MD's relationship with the analyst and VP team?
The primary change is in the feedback model. Instead of editing drafts, the MD directs revisions based on a structured diagnostic—telling the team precisely what sections need to be rebuilt and why. This is more efficient for the MD and more instructive for the team. Analysts and VPs receive feedback that explains what is analytically missing, not just what sounds wrong stylistically.
What is the most important prompt to get right in this workflow?
The investment thesis prompt. Give Claude your own rough articulation of why the deal is worth doing—your actual analytical view, even if it is expressed as bullet points or rough notes—and ask it to structure that into a thesis section. The quality of the thesis output is directly proportional to the specificity of the input you provide. Generic inputs produce generic theses. Your specific analytical view, well-prompted, produces a thesis that reads like the MD's best thinking.
Does this workflow apply to deal meetings other than IC presentations?
Yes. The deal meeting preparation component—the Q&A brief, the supporting materials index, the one-sentence summary sheet—applies to any high-stakes deal conversation: lender presentations, management team meetings, LP update calls, sponsor negotiations. The memo production workflow is IC-specific, but the meeting preparation framework is portable across the deal cycle.